Head-to-head · computed 2026-08-11
Gala GLP-1 vs Sprout Health
Gala GLP-1: Gala GLP-1 is an all-50-state compounded GLP-1 service offering a range of pricing by product tier, including a microdosing option. Its standard all-dose rate is $179/mo (tirz) and $179/mo (sema) with a microdosing tier starting at $149. Sprout Health: Sprout Health sells flat-rate compounded GLP-1s with no membership: $249/month semaglutide (commonly $199 first month; $615 three-month supply, about $205/month) and $299/month tirzepatide (commonly $249 first month), with a published price-lock so the rate holds as the dose climbs — and, unusually for this market, two named partner pharmacies.
Tirzepatide
| Gala GLP-1 | Sprout Health | |
|---|---|---|
| All-in maintenance | $179/mo | $299/mo |
| Best plan rate | $179/mo | $299/mo |
| 12-month total | $2,148 | $3,588 |
| Status | Reported · 2026-07-14 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, Gala GLP-1's $179 a month undercuts Sprout Health's $299 by $120 a month at the 10 mg/wk maintenance basis — $1,440 across a year. Gala GLP-1's figure is reported (captured 2026-07-14) and Sprout Health's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Gala GLP-1's tirzepatide ladder runs $179 a month billed monthly, and $199 a month on a three-month plan. Sprout Health's runs $299 a month billed monthly. On the twelve-month basis Gala GLP-1's $2,148 beats Sprout Health's $3,588 by $1,440 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Sprout Health promotional terms: First month commonly $249.
Semaglutide
| Gala GLP-1 | Sprout Health | |
|---|---|---|
| All-in maintenance | $179/mo | $249/mo |
| Best plan rate | $179/mo | $205/mo |
| 12-month total | $2,148 | $2,988 |
| Status | Reported · 2026-07-14 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, Gala GLP-1's $179 a month undercuts Sprout Health's $249 by $70 a month at the 2.4 mg/wk maintenance basis — $840 across a year. Gala GLP-1's figure is reported (captured 2026-07-14) and Sprout Health's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Gala GLP-1's semaglutide ladder runs $179 a month billed monthly, and $199 a month on a three-month plan. Sprout Health's runs $249 a month billed monthly, and $205 a month on a three-month plan. On the twelve-month basis Gala GLP-1's $2,148 beats Sprout Health's $2,988 by $840 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Sprout Health promotional terms: First month commonly $199; three-month supply $615 (~$205/mo).
Structure, side by side
Gala GLP-1
- MembershipNone
- Dose policyFlat at 'all doses' for standard plan; separate microdosing tier at $149
- Commitment3-month plan or standard monthly; confirm exact terms at enrollment
- CancellationPer provider terms
- PharmacyPartner 503A pharmacies (not named publicly)
Sprout Health
- MembershipNone
- Dose policyDose-flat with a published price-lock guarantee: the enrolled rate does not increase as the dose escalates
- CommitmentMonth-to-month; 3-month semaglutide supply available
- CancellationPer provider terms
- PharmacyFoothills Pharmacy and Promise Pharmacy (named partners)
What our desk is watching on each
Gala GLP-1: Gala lists a range rather than one fixed price: the hero says $179/mo 'all doses', the FAQ says $199/mo 'with a 3-month plan', and $149/mo is listed for microdosing. This makes 'all-in maintenance' ambiguous; we rank on the $179 standard figure with a note. Exact ongoing rate must be confirmed at enrollment. Reported status from RangeYourself 2026-07-14.
Sprout Health: Resolution on record: our July 16 homepage read ('starting-at entry-dose prices; funnel personalizes') is superseded — five independent 2026 sources converge on flat $249/$299 pricing with an explicit dose price-lock, identifying the homepage 'starting at' as first-month promo framing rather than dose tiering. LegitScript-certified; MD Integrations clinician network; Sprout Health Partners LLC, Encinitas, CA. Cautions that survive the upgrade: a consistent slow-customer-service complaint pattern across review sources, an NAD+ add-on on the menu (see the verification masterclass's add-on cautions), oral compounded tirzepatide tablets offered (less outcome data than injectables), and no labs or telehealth visit required before treatment — fast is not the same as thorough.
Questions people ask
Is Gala GLP-1 or Sprout Health cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Gala GLP-1 vs Sprout Health miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Gala GLP-1 and Sprout Health cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $2,148 at Gala GLP-1 and $3,588 at Sprout Health — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Does a promotion affect this comparison?
Yes — at least one program on this page (Sprout Health) is running promotional pricing with its standard rate card stored alongside it. The verdict uses the price a buyer pays today, labeled as promotional; the analysis block prints the reversion figure, because a comparison won on a sale that ends is a comparison that expires.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Gala GLP-1 · Sprout Health. Official sites: Gala GLP-1 ↗ · Sprout Health ↗. Nothing here is medical advice.